Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A

Conclusions Despite Cpd A having a potential role in reducing cancer cell metastasis, identification of strong predictive biomarkers of c-Met sensitivity would be essential to the development of a c-Met targeted treatment for an appropriately selected cohort of TNBC patients.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research